Prolonged persistence of mutagenic DNA lesions in somatic cells
Nature,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
Abstract
DNA
is
subject
to
continual
damage,
leaving
each
cell
with
thousands
of
individual
lesions
at
any
given
moment
1–3
.
The
efficiency
repair
means
that
most
known
classes
lesion
have
a
half-life
minutes
hours
3,4
,
but
the
extent
which
damage
can
persist
for
longer
durations
remains
unknown.
Here,
using
high-resolution
phylogenetic
trees
from
89
donors,
we
identified
mutations
arising
818
persisted
across
multiple
cycles
in
normal
human
stem
cells
blood,
liver
and
bronchial
epithelium
5–12
Persistent
occurred
increased
rates,
distinctive
mutational
signatures,
donors
exposed
tobacco
or
chemotherapy,
suggesting
they
arise
exogenous
mutagens.
In
haematopoietic
cells,
persistent
lesions,
probably
endogenous
sources,
generated
characteristic
signature
SBS19
13
;
steadily
throughout
life,
including
utero;
endured
2.2
years
on
average,
15–25%
lasting
least
3
years.
We
estimate
has
approximately
eight
such
time,
half
will
generate
mutation
cycle.
Overall,
16%
blood
are
attributable
SBS19,
similar
proportions
driver
cancers
exhibit
this
signature.
These
data
indicate
existence
family
mutagens,
present
low
numbers
per
genome,
months
years,
substantial
fraction
burden
somatic
cells.
Language: Английский
Prolonged persistence of mutagenic DNA lesions in stem cells
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 23, 2023
Abstract
DNA
suffers
continual
damage
leaving
a
cell
with
thousands
of
individual
lesions
at
any
given
moment
1–3
.
The
efficiency
repair
means
that
most
known
classes
lesion
have
half-life
minutes
to
hours
3,4
,
but
whether
some
can
persist
for
longer
durations
remains
unknown.
Here,
using
high-resolution
phylogenetic
trees
from
89
donors,
we
identified
mutations
arising
832
persisted
across
multiple
cycles
in
normal
human
stem
cells
blood,
liver
and
bronchial
epithelium
5–12
Persistent
occurred
increased
rates,
distinctive
mutational
signatures,
donors
exposed
tobacco
or
chemotherapy,
suggesting
they
arise
exogenous
mutagens.
In
haematopoietic
cells,
persistent
lesions,
likely
endogenous
sources,
generated
characteristic
signature,
so-called
SBS19
13
;
steadily
throughout
life,
including
utero
endured
1.5
years
on
average,
15%
lasting
3+
years.
We
estimate
has,
~4-5
such
time,
half
which
will
generate
mutation
each
cycle.
Overall,
16%
blood
are
attributable
SBS19,
similar
proportions
driver
cancers
exhibit
this
signature.
These
data
imply
the
existence
family
both
mutagens,
present
low
numbers
per
genome
persisting
months
years,
sizable
fractions
cells’
burdens.
Language: Английский
Understanding exposomes and its relation with cancer risk in Malaysia based on epidemiological evidence: a narrative review
Genes and Environment,
Journal Year:
2024,
Volume and Issue:
46(1)
Published: Feb. 8, 2024
Abstract
The
prevalence
of
cancer
is
increasing
globally,
and
Malaysia
no
exception.
exposome
represents
a
paradigm
shift
in
research,
emphasizing
the
importance
holistic
approach
that
considers
cumulative
effect
diverse
exposures
encountered
throughout
life.
include
dietary
factors,
air
water
pollutants,
occupational
hazards,
lifestyle
choices,
infectious
agents
social
determinants
health.
concept
acknowledges
each
individual’s
risk
shaped
by
not
only
their
genetic
makeup
but
also
unique
life
experiences
environmental
interactions.
This
comprehensive
review
was
conducted
systematically
searching
scientific
databases
such
as
PubMed,
Scopus
Google
Scholar,
using
keywords
“exposomes
(environmental
AND/OR
physical
chemical
exposures)
AND
Malaysia”,
for
relevant
articles
published
between
2010
2023.
Articles
addressing
relationship
exposomes
Malaysian
population
were
critically
evaluated
summarized.
aims
to
provide
an
update
on
epidemiological
evidence
linking
with
Malaysia.
will
current
findings
research
related
identified
exposomes-omics
interaction
gap
area
subject
matter.
Understanding
interplay
complex
carcinogenesis
holds
potential
unveil
novel
preventive
strategies
may
be
beneficial
public
Language: Английский
DNA Adductomics: A Narrative Review of Its Development, Applications, and Future
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1173 - 1173
Published: Sept. 19, 2024
DNA
adductomics
is
the
global
study
of
all
adducts
and
was
first
proposed
in
2006
by
Matsuda
group.
Its
development
has
been
greatly
credited
to
advances
mass
spectrometric
techniques,
particularly
tandem
multiple-stage
spectrometry.
In
fact,
liquid
chromatography-mass
spectrometry
(LC-MS)-based
methods
are
virtually
sole
technique
with
practicality
for
adductomic
studies
date.
At
present,
primarily
used
as
a
tool
search
adducts,
known
unknown,
providing
evidence
exposure
exogenous
genotoxins
and/or
molecular
mechanisms
their
genotoxicity.
Some
discovered
this
way
have
potential
predict
cancer
risks
be
associated
adverse
health
outcomes.
successfully
identify
determine
carcinogens
that
may
contribute
etiology
certain
cancers,
including
bacterial
an
N-nitrosamine.
Also
using
approach,
multiple
observed
show
age
dependence
serve
aging
biomarkers.
These
achievements
highlight
capability
power
medicine,
biological
science,
environmental
science.
Nonetheless,
still
its
infancy,
great
expected
future.
Language: Английский
Multi-adductomics: Advancing mass spectrometry techniques for comprehensive exposome characterization
TrAC Trends in Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
180, P. 117900 - 117900
Published: Aug. 5, 2024
Language: Английский
DNA Repair Status as a Guide for Pancreatic Ductal Adenocarcinoma Treatment, an Old View for a New Future.
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
604, P. 217222 - 217222
Published: Sept. 7, 2024
Language: Английский
Repair Assisted Damage Detection (RADD) as a predictive biomarker for immunotherapy response in ovarian cancer
Manoj Sonavane,
No information about this author
Jenna Hedlich-Dwyer,
No information about this author
Valeria L. Dal Zotto
No information about this author
et al.
Gynecologic Oncology,
Journal Year:
2024,
Volume and Issue:
192, P. 65 - 72
Published: Nov. 14, 2024
Genomic
instability
has
been
proposed
as
a
predictive
biomarker
for
immunotherapy
in
ovarian
cancer.
We
tested
method
measuring
DNA
damage,
direct
measure
of
genomic
instability,
tumors
and
its
ability
to
predict
response
Vigil
(gemogenovatucel-T).
Language: Английский